Back
Enanta Pharmaceuticals Vs. Akero Therapeutics Industry Stock Comparison
Sell
26
ENTA
Enanta Pharmaceuticals
Last Price:
12.62
Seasonality Move:
-0.7%
Sell
34
AKRO
Akero Therapeutics
Last Price:
19.65
Seasonality Move:
17.5%
Sell
26
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy, Sell or Hold?
- The current Enanta Pharmaceuticals [ENTA] share price is $12.65. The Score for ENTA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- ENTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $19.65. The Score for AKRO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ENTA Stock Price Chart
What is Enanta Pharmaceuticals's stock price today?
-
The Enanta Pharmaceuticals share price today is $12.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $19.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
ENTA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 40.07 | Sell |
Chaikin Money Flow: | -93495 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.71 - 15.69) | Sell |
Bollinger Bands (100): | (11.22 - 15.34) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.69 | Sell |
Relative Strength Index (14 RSI): | 39.39 | Sell |
Chaikin Money Flow: | -530509 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.8 - 22.16) | Sell |
Bollinger Bands (100): | (20.24 - 26.04) | Sell |
ENTA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.59 | Sell |
20-day SMA: | 13.6 | Sell |
50-day SMA: | 14.76 | Sell |
200-day SMA: | 12.58 | Buy |
8-day EMA: | 13.27 | Sell |
20-day EMA: | 13.77 | Sell |
50-day EMA: | 14.04 | Sell |
200-day EMA: | 16.19 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.63 | Sell |
20-day SMA: | 20.59 | Sell |
50-day SMA: | 23.81 | Sell |
200-day SMA: | 27.64 | Sell |
8-day EMA: | 20.57 | Sell |
20-day EMA: | 20.99 | Sell |
50-day EMA: | 22.23 | Sell |
200-day EMA: | 26.78 | Sell |
Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.36 per share, and an increase next year of $0.46 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.23 per share, a decrease this year of $0.91 per share, and a decrease next year of $0.58 per share.
Enanta Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |